Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 5, 1998, Pages 513-517

  Vorland, Lars H ^a,b   Ulvatne, Hilde ^a   Andersen, Jill ^a   Haukland, Hanne H ^a   Rekdal, Øystein ^b   Svendsen, John S ^b   Gutteberg, Tore J ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; LACTOFERRIN; PEPSIN A;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; CANDIDA ALBICANS; CANDIDA TROPICALIS; CATTLE; CRYPTOCOCCUS NEOFORMANS; ESCHERICHIA COLI; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; PROTEUS MIRABILIS; STAPHYLOCOCCUS AUREUS; YERSINIA ENTEROCOLITICA;

EID: 0032411892     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365549850161557     Document Type: Article

References (36)

1. Kagan BL, Selsted ME, Ganz T, Lehrer RI. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci USA 1990; 87: 210-4.
2. Ganz T, Oren A, Lehrer RI. Defensins: microbicidal and cytotoxic peptides of mammalian host defense cells. Med Microbiol Immunol 1992; 1881: 99-105.
3. Nakamura T, Furunaka H, Miyata T, Tokuaga F, Muta T, Iwanaga S. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). J Biol Chem 1988; 263: 16709-13.
4. Tomita M, Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J Dairy Science 1991; 74: 4137-42.
5. Masson PL, Heremans JF, Prignot JJ, Wauters G. An iron-binding protein common to many external secretions. Clin Chim Acta 1966; 14: 735-9.
6. Bullen JJ, Rogers HJ, Griffiths E. Role of iron in bacterial infection. Curr Top Microbiol Immunol 1978; 80: 1-35.
7. Cohen MS, Britigan BE, French M, Bean K. Preliminary observations on lactoferrin secretion in human vaginal mucus: variation during the menstrual cycle, evidence of hormonal regulation, and implications for infection with Neisseria gonorrhoeae. Am J Obstet Gynecol 1987; 157: 1122-5.
8. Gutteberg TJ, Dalaker K, Vorland LH. Early response in neonatal septicemia. The effect of Escherichia coli, Streptococcus agalactiae and tumor necrosis factor on the generation of lactoferrin. APMIS 1990; 98: 1027-32.
9. Otto BR, Verweij-van Vught AMJJ, MacLaren DM. Transferrins and heme-compounds as iron sources for pathogenic bacteria. Crit Rev Microbiol 1992; 18: 217-33.
10. Ellison RT III, Giehl TJ, LaForce FM. Damage of the outer membrane of enteric Gram-negative bacteria by lactoferrin and transferrin. Infect Immun 1988; 56: 2774-81.
11. Erdei J, Forsgren A, Satyanarayan Naidu A. Lactoferrin binds to porins OmpF and OmpC in Escherichia coli. Infect Immun 1994; 62: 1236-40.
12. Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K, Tomita M. Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta 1992; 1121: 130-6.
13. Dionysius D A, Milne JM. Antibacterial peptides of bovine lactoferrin: Purification and characterization. J. Dairy Sci. 1997; 80: 667-74.
14. Hoek KS, Milne JM, Grieve PA, Dionysius DA, Smith R. Antibacterial activity of bovine lactoferrin-derived peptides. Antimicrob Agents Chemother 1997; 41: 54-9.
15. Bellamy W, Takase M, Wakabayashi H, Kawase K, Tomita M. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol 1992; 73: 72-9.
16. Bellamy W, Wakabayashi H, Takase M, Kawase K, Shimamura S, Tomita M. Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med Microbiol Immonol 1993; 182: 97-105.
17. Turchany JM, Aley SB, Gillin FC. Giardicidal activity of lactoferrin and N-terminal peptides. Infect Immun 1995; 63: 4550-2.
18. Isamida T, Tanaka T, Omata Y, Yamauchi K, Shimazaki K, Saiko A. Protective effect of lactoferricin against Toxoplasma gondii infection in mice. J Vet Med Sci 1998; 60: 241-4.
19. Pentecost BT, Teng CT. Actotransferrin is the major estrogen inducible protein of mouse uterine secretions. J Biol Chem 1987; 262: 10134-9.
20. Provost FL, Nocart M, Guerin G, Martin P. Characterization of the goat lactoferrin cDNA: assignement of the relevant locus to bovine U12 synteny group. Biochem Biophys Res Commun 1994; 203: 1324-32.
21. Yamauchi K, Tomita M, Giehl TJ, Ellison RT III. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 1993; 61: 719-28.
22. Amsterdam D. Susceptibility testing of antimicrobials in liquid media. In Lorian V, ed. Antibiotics in laboratory medicine 4th edn: Williams & Eilikins, 1996: 75-8.
23. Rekdal Ø, Andersen J, Vorland LH, Svendsen JS. The construction and synthesis of lactoferricin derivatives with enhanced antibacterial activity. J Pept Sci (in press).
24. Hagiwara T, Shinoda I, Fukuwatari Y, Shimamura S. Effects of lactoferrin and its peptides on proliferation of rat intestinal epithelial cell line, IEC-18, in the presence of epidermal growth factor. Biosci Biotech Biochem 1995; 59: 1875-81.
25. Brogan TD, Ryley HC, Neale L, Yassa J. Soluble proteins of bronchopulmonary secretions from patients with cystic fibrosis, asthma, and bronchitis. Thorax 1975; 30: 72-9.
26. Tabak L, Mandel ID, Herrera M, Baurmash H. Changes in lactoferrin and other proteins in case of chronic parotitis. J Oral Pathol 1978; 7: 91-9.
27. Gutteberg TJ, Haneberg B, Jørgensen T. The latency of serum acute phase proteins in meningococcal septicemia, with special emphasis on lactoferrin. Clin Chim Acta 1984; 136: 173-8.
28. LaForce FM, Boose DS. Release of lactoferrin by polymorphonuclear leukocytes after aerosol challenge with Escherichia coli. Infect Immun 1987; 55: 2293-5.
29. Tomita M. Active peptides of lactoferrin. Indigenous antimicrobial agents of milk: recent developments. Proceedings of the International Dairy Federation Seminar 1994: 7-13.
30. Bellamy WR, Wakabayashi H, Takase M, Kawase K, Shimamura S, Tomita M. Role of cell-binding in the antibacterial mechanism of lactoferricin B. J Appl Bacteriol 1993; 75: 478-84.
31. Jones EM, Smart A, Bloomberg G, Burgess L, Millar MR. Lactoferricin, a new antimicrobial peptide. J Appl Bacteriol 1994; 77: 208-14.
32. Kang JH, Lee MK, Kim KL, Hahm K-S. Structure-biological activity relationships of 11- residue highly basic peptide segment of bovine lactoferrin. Int J Peptide Protein Res 1996; 48: 357-63.
33. Chapple DS, Mason DJ, Joannou CL, Odell EW, Gant V, Evans RW. Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111. Infect Immun 1998; 66: 2434-40.
34. Nikaido H, Vaara M. The molecular basis of bacterial outer membrane permeability. Microbiol Rev 1985; 49: 1-32.
35. Sidorczyk A, Zahringer U, Rietschel ET. Chemical structure of the lipid A component of the lipopolysaccharide from a Proteus mirabilis Re-mutant. Eur J Biochem 1983; 137: 15-22.
36. Wakabayashi H, Hiratani T, Uchida K, Yamaguchi H. Antifungal spectrum and fungicidal mechanism of an N-terminal peptide of bovine lactoferrin. J Infect Chemother 1996; 1: 185-9.